EXECUTIVE SUMMARY
1. MARKET OVERVIEW
1.1 Trends in the Global Clinical Diagnostics Market
1.2 Clinical Diagnostics Market and Technology Trends by Segment
1.2.1 Clinical Chemistry
1.2.2 Immunodiagnostics
1.2.3 Hematology and Coagulation
1.2.4 Microbiology
1.2.5 Molecular Diagnostics
1.3 Trends in Laboratory Restructuring and the Organization of Testing
1.4 Factors Driving the Adoption of Point-of-Care Testing
1.5 Regulatory Trends Impacting the Use of Point-of-Care Testing
1.6 Cost and Reimbursement Issues in Point-of-Care Testing
1.7 Quality Control and Quality Assurance Issues in Point-of-Care Testing
1.8 Trends in Self-Monitoring, Disease Screening, Wellness Testing, Risk Assessment and Preventative Testing
1.9 Changes in the Site of Health Care Delivery
2. HOSPITAL-BASED POINT-OF-CARE TESTING PRODUCTS
2.1 Hospital Diagnostic Testing Environment
2.1.1 Bedside Critical Care Testing Products Market
2.1.2 Trends in POC Critical Care Test Volume and Equipment Installed Base
2.1.3 Existing POC Critical Care Testing Products
2.1.4 New Technologies Under Development for POC Bedside Critical Care Testing
2.2.4 Bedside Critical Care Testing Market Analysis and Forecast
2.2.5 Bedside Critical Care Testing Product Suppliers' Sales and Market Shares
2.2.6 Drivers and Limiters of the Hospital POC Critical Care Testing Products Market
2.3 Hospital Bedside Hemostasis Testing Products Market
2.3.1 Trends in POC Hemostasis Test Volume and Equipment Installed Base
2.3.2 Existing POC Hemostasis Testing Products
2.3.3 New Products and Technologies Under Development for POC Hemostasis Testing
2.3.4 Hospital-Based POC Hemostasis Testing Market Analysis and Forecast
2.3.5 Hospital-Based POC Hemostasis Testing Product Suppliers' Sales and Market Shares
2.3.6 Drivers and Limiters of the Hospital POC Hemostasis Testing Products Market
2.4 Bedside/POC Drugs of Abuse Testing Products Market
2.4.1 Trends in Bedside/POC Drugs of Abuse Testing
2.4.2 Existing Bedside/POC Drugs of Abuse Testing Products
2.4.3 New Bedside/POC Drugs of Abuse Testing Products Under Development
2.4.4 POC Drugs of Abuse Testing Market Analysis and Forecast
2.4.5 POC Drugs of Abuse Testing Product Suppliers' Sales and Market Shares
2.4.6 Drivers and Limiters of the Hospital POC Drugs of Abuse Testing Products Market
2.5 POC Cardiac Marker Testing Products Market Analysis
2.5.1 Trends in POC Testing for Cardiovascular Disease
2.5.2 POC Cardiac Marker Products Under Development
2.5.3 POC Cardiac Marker Market Analysis and Forecast
2.5.4 POC Cardiac Marker Product Suppliers' Sales and Market Shares
2.5.5 Drivers and Limiters of the POC Cardiac Marker Testing Products Market
2.6 Other Bedside/POC Testing Products Markets
2.6.1 POC Infectious Disease Testing Products, Market Analysis and Suppliers
2.6.2 POC Products and Markets for Hemoglobin and Hematocrit Testing
2.6.3 Hospital and Institutional Bedside Whole Blood Glucose Monitoring Market
2.6.3.1 Products for Hospital/Institutional Bedside Whole Blood Glucose Monitoring
2.6.3.2 Hospital/Institutional Bedside Whole Blood Glucose Monitoring Market Analysis
2.6.3.3 Drivers and Limiters of the Hospital/Institutional Bedside Whole Blood Glucose Monitoring Products Market
3. HOME AND SELF-TESTING PRODUCTS
3.1 Whole Blood Glucose Self-Testing Products Market
3.1.1 Existing Whole Blood Glucose Self-Testing Products
3.1.2 Development-Stage Whole Blood Glucose Self-Testing Products
3.1.2.1 Integrated Glucose Testing Devices
3.1.2.2 Implantable Glucose Monitors
3.1.2.3 Non-Invasive Glucose Monitoring
3.1.3 Whole Blood Glucose Self-Testing Products Market Analysis and Forecast
3.1.4 Whole Blood Glucose Self-Testing Product Suppliers' Sales and Market Shares
3.1.5 Drivers and Limiters of the Whole Blood Glucose Self-Testing Products Market
3.2 OTC Pregnancy and Fertility Testing Products Market
3.2.1 Trends in Home Pregnancy and Fertility Testing
3.2.2 Existing Products for Home Pregnancy and Fertility Testing
3.2.3 New Products Under Development for Home Pregnancy and Fertility Testing
3.2.4 OTC Pregnancy and Fertility Testing Products Market Analysis and Forecast
3.2.5 OTC Pregnancy and Fertility Testing Product Suppliers' Sales and Market Shares
3.2.6 Drivers and Limiters of the OTC Pregnancy and Fertility Testing Products Market
3.3 Markets for Other Home and Self-Testing Products
3.3.1 Cholesterol Self-Testing
3.3.2 Fecal Occult Blood Testing
3.3.3 Home Drugs of Abuse Testing
3.3.4 Coagulation Self-Testing
3.3.5 Infectious Disease Self-Testing
3.3.6 Home Heart Failure Monitoring
3.3.7 Home Thyroid and Anemia Testing
CHAPTER 4: PHYSICIANS OFFICE AND OTHER ALTERNATE SITE TESTING PRODUCTS
4.1 Types of Testing Performed in Physician Offices and Other Alternate Sites
4.2 Existing Physician’s Office Laboratory Products
4.3 New POL Products Under Development
4.4 Physician’s Office Laboratory Market Analysis
4.5 POL Product Suppliers' Sales and Market Shares
4.6 Drivers and Limiters of the Worldwide POL Products Market
4.7 Other Alternate Site Testing Products and Markets
CHAPTER 5: COMPETITOR ASSESSMENT
5.1 Overview of Companies in the Global POC Diagnostics Market
5.2 Mergers and Partnerships to Improve Competitive Position
5.3 Technology Portfolio Analysis for Leading POC Diagnostics Companies
5.4 Marketing and Distribution Strategies for the Global POC Diagnostics Market
CHAPTER 6: COMPANY PROFILES
6.1 Abaxis
6.2 Abbott Laboratories
6.3 Accumetrics
6.4 Alfa Wassermann
6.5 Arkray
6.6 Axis-Shield
6.7 Bayer Diabetes Care
6.8 Beckman Coulter
6.9 Cepheid
6.10 Dexcom
6.11 Genzyme
6.12 Helena Labs
6.13 Hemocue
6.14 Home Diagnostics
6.15 IDEXX Laboratories/OPTI Medical
6.16 International Technidyne/Thoratec
6.17 Inverness Medical Innovations
6.17.1 Biosite
6.17.2 HemoSense
6.17.3 Cholestech
6.18 Menarini Diagnostics
6.19 Nanogen/ELITech Group
6.20 OraSure Technologies
6.21 Ortho Clinical Diagnostics/LifeScan
6.22 Phamatech
6.23 Princeton BioMeditech
6.24 QBC Diagnostics/The Drucker Company
6.25 Quidel
6.26 Radiometer A/S
6.27 Response Biomedical
6.28 Roche Diagnostics
6.29 Siemens Diagnostics
6.30 Trinity Biotech
Appendix Company Listing
308 pages